NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 09:30 PM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:59 PM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:03 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
CalciMedica Inc reports results for the quarter ended June 30 - Earnings Summary
CalciMedica Q2 net loss widens
CalciMedica Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Calcimedica - Prospectus Covers Resale Of Up To 56,020,287 Shares Of Common Stock - SEC Filing
Brief: Calcimedica Announces Private Placement Financing For Up To Approximately $49 Million To Advance Pulmonary Hypertension Program
Brief: Calcimedica Announces Clinical Development Of Auxora May Proceed Following FDA Review Of Kourage Trial Interim Safety Data
Brief: Calcimedica - Enters First Amendment To Loan And Security Agreement On June 23, 2026 - SEC Filing
CalciMedica posts Q1 profit on higher other income, lower expenses
Brief: Calcimedica Inc Files For Mixed Shelf Of Up To $125 Million - SEC Filing
Brief: Calcimedica Discontinues Phase 2 Kourage Trial
U.S. STOCKS ON THE MOVE-Applied Materials, Sherwin-Williams, Caterpillar
NASDAQ RESUMED AT 11:02 AM